本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Jasper Therapeutics

5.41
+0.03000.56%
盘后5.410.00000.00%17:56 EDT
成交量:12.59万
成交额:68.10万
市值:8,126.97万
市盈率:-1.11
高:5.57
开:5.40
低:5.23
收:5.38
数据加载中...
2025/03/25

SEC问询函

Form CORRESP - Correspondence
2025/03/19

重要事件披露

Form 8-K - Current report
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments